arginine has been researched along with Embolism, Pulmonary in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.00) | 18.7374 |
1990's | 5 (12.50) | 18.2507 |
2000's | 15 (37.50) | 29.6817 |
2010's | 14 (35.00) | 24.3611 |
2020's | 4 (10.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, T; Gohma, I; Kohata, H; Kohno, M; Kumasawa, J; Nagata, T; Nishida, K; Ogawa, Y | 1 |
Daniels, LM; Sagardia, LM | 1 |
Enright, H; Fahy, A; McGlynn, F; McGrath, J; McHugh, J; Ryan, B; Varghese, C | 1 |
Gandotra, P; Garra, G; Gruberg, L; Selim, S; Supariwala, A | 1 |
Ahmed, MI; Bethea, BT; Elliot, JW; Richardson, JB | 1 |
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A | 1 |
Dai, G; Liu, Q; Sun, L; Wang, C | 1 |
Pötzsch, B | 1 |
Courtney, D; Hwang, S; Kline, JA; Lee, YY; Watts, J | 1 |
Burger, CF; Schlesinger, JJ | 1 |
Akar, O; Celik, S; Günay, E; Halici, B; Nural, S; Sarinc Ulasli, S; Sen, S; Unlu, M | 1 |
Bhalla, MC; Frey, JA; Hourmouzis, Z; Jwayyed, S | 1 |
Deveci, F; İn, E; Kaman, D | 1 |
Jiji, RS; Michaels, AD | 1 |
Fries, D | 1 |
Gellar, MA; Kline, JA; Marchick, MR; Watts, JA | 1 |
Edo, K; Ishibashi, T; Ishikawa, K; Maruyama, Y; Ogata, H; Takahashi, T; Watanabe, M | 1 |
Altın, R; Altuntaş, M; Atalay, F; Can, M; Tor, M | 1 |
Das, SK; Fulkerson, MB; Gellar, MA; Kline, JA; Watts, JA | 1 |
Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R | 1 |
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K | 1 |
Hayashi, T; Kaneko, M; Nakao, Y; Nomura, T; Nonaka, Y; Okamura, J; Suyama, Y | 1 |
Gerlach, RF; Metzger, IF; Rocha, JB; Souza-Costa, DC; Tanus-Santos, JE; Zerbini, T | 1 |
Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH | 1 |
Rice, L | 1 |
Dias-Junior, CA; Evora, PR; Moreno, H; Souza-Silva, AR; Tanus-Santos, JE; Uzuelli, JA | 1 |
Gerlach, RF; Palei, AC; Souza-Costa, DC; Tanus-Santos, JE; Zerbini, T | 1 |
Tanus-Santos, JE | 1 |
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G | 1 |
Durr, EA; Krueger, CD; Shapiro, NL | 1 |
Bai, M; Xia, L; Yang, W; Zhang, J; Zhang, X | 1 |
Abiko, Y; Kumada, T | 1 |
Bignell, P; Cooper, DN; Girolami, A; Girolami, B; Kakkar, VV; Marchiori, A; Millar, DS; Simioni, P | 1 |
Dikshit, M; Kumari, R; Srimal, RC | 1 |
Bernardi, F; Hendricx, S; Jude, B; Strecker, A; Wolschies, E | 1 |
Alberti, PF; Emerson, M; Gresele, P; Momi, S; Page, C; Paul, W | 1 |
Isoyama, S; Kumagai, T; Kumasaka, N; Odaka, H; Okayama, H; Sakuma, M; Seki, T; Shirato, K | 1 |
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M | 1 |
3 review(s) available for arginine and Embolism, Pulmonary
Article | Year |
---|---|
[Anticoagulation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
[Anticoagulation in critically ill patient].
Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis | 2009 |
Evolving management strategies for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin | 2005 |
1 trial(s) available for arginine and Embolism, Pulmonary
Article | Year |
---|---|
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2005 |
36 other study(ies) available for arginine and Embolism, Pulmonary
Article | Year |
---|---|
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Heparin; Host-Pathogen Interactions; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2020 |
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
Topics: Adult; Anticoagulants; Arginine; Coronavirus Infections; COVID-19; Fibrinolytic Agents; Heart Arrest; Heparin, Low-Molecular-Weight; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; Sulfonamides; Thrombolytic Therapy; Treatment Failure; Treatment Outcome | 2020 |
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection.
Topics: Adult; Anticoagulants; Arginine; Catheter Obstruction; COVID-19; Drug Resistance; Drug Substitution; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient.
Topics: Anticoagulants; Antithrombins; Aorta, Thoracic; Arginine; Biomarkers; COVID-19; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombosis | 2021 |
Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Catheterization; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Interventional | 2017 |
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis | 2017 |
Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study.
Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Pipecolic Acids; Postoperative Care; Preoperative Care; Prospective Studies; Prothrombin Time; Pulmonary Embolism; Rivaroxaban; Sulfonamides; Thrombelastography; Thrombophilia; Venous Thrombosis | 2019 |
Severe pulmonary embolism decreases plasma L-arginine.
Topics: Arginase; Arginine; Chromatography, High Pressure Liquid; Echocardiography, Doppler; Hemolysis; Humans; Hypertension, Pulmonary; Prospective Studies; Pulmonary Embolism; Tricuspid Valve; Tricuspid Valve Insufficiency | 2014 |
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2014 |
Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: follow-up results.
Topics: Adult; Aged; Antioxidants; Arginine; Case-Control Studies; Female; Follow-Up Studies; Humans; Hypoxia; Inflammation; Interleukin-6; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pulmonary Embolism; Risk Factors; Tumor Necrosis Factor-alpha | 2014 |
Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
Topics: Antithrombins; Arginine; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tissue Plasminogen Activator | 2015 |
Assessment of heat shock proteins and endothelial dysfunction in acute pulmonary embolism.
Topics: Acute Disease; Adult; Aged; Arginine; Biomarkers; Case-Control Studies; Endothelium, Vascular; Female; Gene Expression; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Male; Middle Aged; Molecular Chaperones; Oxidative Stress; Oxygen; Pulmonary Artery; Pulmonary Embolism | 2016 |
Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Disseminated Intravascular Coagulation; Embolectomy; Heparin; Humans; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Vena Cava Filters | 2008 |
Up-regulation of arginase II contributes to pulmonary vascular endothelial cell dysfunction during experimental pulmonary embolism.
Topics: Animals; Arginase; Arginine; Endothelial Cells; Male; Nitric Oxide Synthase Type III; Pulmonary Artery; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasodilation | 2011 |
Effects of oral supplementation of L-arginine in the treatment of pulmonary hypertension secondary to pulmonary embolism: a case report.
Topics: Administration, Oral; Arginine; Dietary Supplements; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Natriuretic Peptide, Brain; Pulmonary Embolism | 2010 |
Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolism.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Female; Homocysteine; Humans; Male; Middle Aged; Nitrates; Oxygen; Partial Pressure; Predictive Value of Tests; Prognosis; Pulmonary Embolism; Pulmonary Wedge Pressure; Risk Factors; Vitamin B 12 | 2011 |
Arginase depletes plasma l-arginine and decreases pulmonary vascular reserve during experimental pulmonary embolism.
Topics: Animals; Arginase; Arginine; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hemodynamics; Hemoglobins; Hemolysis; Hypertension, Pulmonary; Lactic Acid; Male; Microspheres; Pulmonary Circulation; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction | 2012 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin | 2002 |
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography | 2003 |
Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
Topics: Aged; Arginine; Female; Follow-Up Studies; Heparin; Humans; Japan; Pipecolic Acids; Polycythemia Vera; Pulmonary Embolism; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2004 |
l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension.
Topics: Acute Disease; Animals; Arginine; Dextrans; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Pulmonary; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Pulmonary Artery; Pulmonary Embolism; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2005 |
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension.
Topics: Acute Disease; Analysis of Variance; Animals; Arginine; Blood Pressure; Cyclic GMP; Dogs; Female; Heart Rate; Hypertension, Pulmonary; Infusions, Intravenous; Male; Nitrates; Nitrites; Piperazines; Pulmonary Artery; Pulmonary Embolism; Purines; Respiration; Sildenafil Citrate; Sulfones; Time Factors; Vasodilator Agents | 2005 |
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Topics: Animals; Arginine; Electrophoresis, Polyacrylamide Gel; In Vitro Techniques; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Animal; NG-Nitroarginine Methyl Ester; Prospective Studies; Pulmonary Embolism; Rats; Rats, Wistar | 2005 |
L-arginine and pulmonary embolism.
Topics: Animals; Arginine; Dogs; Embolism, Air; Hypertension, Pulmonary; Pulmonary Embolism; Rats | 2006 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).
Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Influence of L-arginine on the expression of eNOS and COX2 in experimental pulmonary thromboembolism.
Topics: Animals; Arginine; Cyclooxygenase 2; Female; Lung; Male; Nitric Oxide Synthase Type III; Pulmonary Embolism; Rats; Rats, Wistar; RNA, Messenger | 2006 |
Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
Topics: Acute Disease; Animals; Antibodies, Anti-Idiotypic; Antigens; Antithrombin III; Arginine; Blood Coagulation Tests; Fibrinolytic Agents; Heparin; Male; Mice; Mice, Inbred Strains; Pipecolic Acids; Pulmonary Embolism; Rabbits; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Thrombophlebitis | 1981 |
A novel dysfunctional protein C (protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++.
Topics: Adult; Aged; Antigens; Arginine; Base Sequence; Calcium; Child; Cysteine; Humans; Immunoblotting; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Polymerase Chain Reaction; Protein C; Pulmonary Embolism; Thrombophlebitis | 1993 |
Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils.
Topics: Adenosine Deaminase; Animals; Arginine; Haplorhini; Hemoglobins; Hydrogen-Ion Concentration; Male; Methylene Blue; Neutrophils; Nitric Oxide; omega-N-Methylarginine; Platelet Aggregation; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1993 |
[Pulmonary embolism disclosing activated protein C resistance].
Topics: Adult; Arginine; Codon; Factor V; Glutamine; Humans; Male; Mutation; Partial Thromboplastin Time; Protein C; Protein C Deficiency; Pulmonary Embolism | 1996 |
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
Topics: Animals; Arginine; Collagen; Enzyme Inhibitors; Epinephrine; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Aggregation; Pulmonary Embolism; Rabbits | 1999 |
Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism.
Topics: Aged; Arginine; Asian People; Factor V; Female; Glutamine; Humans; Japan; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Pulmonary Embolism; Seroepidemiologic Studies | 1998 |
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior | 1987 |